Materials to Increase Minority Involvement in Clinical Trials (MIMICT) creates collaborative opportunities for clinical trial sites and health care providers. MIMICT delivers accurate, trusted, and understandable information designed to enable people with lupus to make informed decisions about participation in clinical trials.
Lupus Clinical Trials: What You Don’t Know Can Hurt You
- Did you know that African Americans are between two and three times more likely to contract (carry? suffer from?) lupus than non-Hispanic whites?
- Did you know that despite their greater risk, African Americans are significantly underrepresented in clinical trial opportunities for lupus-combatting initiatives?
- Did you know that providers can increase African Americans’ involvement in lupus clinical trials by referring to clinical trials as one of their patients’ treatment options for lupus?
- Clinical Trial Sites - If you perform clinical trials for lupus, the MIMICT program offers you critical information that can help increase African Americans’ awareness of and participation in Lupus clinical trial opportunities.
- Providers - If you provide medical services to African Americans, the MIMICT program offers you critical information about lupus clinical trials that can have a significant impact on your patients’ treatment outcomes.
- How and Who - With a goal of increasing minority participation in lupus clinical trials, the U.S. Department of Health and Human Services Office of Minority Health funded the American College of Rheumatology (ACR) to evaluate and disseminate a model supported by educational material.
This project was supported by Grant Numbers 1 CPIMP171138 and 1 CPIMP181166 from the U.S. Department of Health and Human Services office of Minority Health (HHS, OMH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS, OMH.